The article discusses the inhibitors of peptidyl proline isomerases as antivirals in different viruses. Topics discussed include the evidence that cyclophilin A is needed in the hepatitis C virus (HCV) life cycle, whether disordered regions of a proline-rich viral target contributes to the viral protein being a substrate for cyclophilins, and HCV proteins that cyclophilins act.